SURGICAL TREATMENT OF NONALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE

被引：1
|
作者：
Ilias, Elias Jirjoss [1 ]
机构：
[1] Fac Ciencias Med Santa Casa de Sao Paulo, Dept Cirugia, Sao Paulo, Brazil
来源：
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2010年 / 56卷 / 04期
关键词：
D O I：
10.1590/S0104-42302010000400003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [31] Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
    Orlando, R.
    Azzalini, L.
    Orando, S.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [32] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [33] Clinical update on non-alcoholic fatty liver disease and steatohepatitis
    Bugianesi, Elisabetta
    Bellentani, Stefano
    Bedogni, Giorgio
    Tiribelli, Claudio
    Svegliati-Baroni, Gianluca
    Croce, Lory S.
    Gastaldelli, Amalia
    Marchesini, Giulio
    Marra, Fabio
    Perseghin, Gianluca
    Tell, Gianluca
    ANNALS OF HEPATOLOGY, 2008, 7 (02) : 157 - 160
  • [34] Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Bandyopadhyay, Sanjay
    Das, Saibal
    Samajdar, Shambo Samrat
    Joshi, Shashank R.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (10)
  • [35] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Angelico, F.
    Burattin, M.
    Alessandri, C.
    Del Ben, M.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [36] What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 425 - 428
  • [37] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
  • [38] Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Ahsan, Farah
    Oliveri, Federico
    Goud, Harshit K.
    Mehkari, Zainab
    Mohammed, Lubna
    Javed, Moiz
    Althwanay, Aldanah
    Rutkofsky, Ian H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [39] The importance of regular screening for HCC in non-alcoholic steatohepatitis/non-alcoholic fatty liver disease
    Keitoku, Taisei
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Ishido, Shun
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Huang, Hiroyuki Nakanishi Daniel
    Izumi., Namiki
    Red, Musashino
    JOURNAL OF HEPATOLOGY, 2023, 78 : S644 - S644
  • [40] Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Mohammadi, Zahra
    Poustchi, Hossein
    Motamed-Gorji, Nazgol
    Eghtesad, Sareh
    Hekmatdoost, Azita
    Saniee, Parastoo
    Merat, Shahin
    ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (01) : 44 - 52
12345